309 related articles for article (PubMed ID: 25993630)
21. MELAS and L-arginine therapy.
Koga Y; Akita Y; Nishioka J; Yatsuga S; Povalko N; Katayama K; Matsuishi T
Mitochondrion; 2007; 7(1-2):133-9. PubMed ID: 17276739
[TBL] [Abstract][Full Text] [Related]
22. [l-arginine efficiency in MELAS syndrome. A case report].
Moutaouakil F; El Otmani H; Fadel H; Sefrioui F; Slassi I
Rev Neurol (Paris); 2009 May; 165(5):482-5. PubMed ID: 18849057
[TBL] [Abstract][Full Text] [Related]
23. Photic stimulation-induced alteration of brain energy metabolism measured by 31P-MR spectroscopy in patients with MELAS.
Kato T; Murashita J; Shioiri T; Terada M; Inubushi T; Kato N
J Neurol Sci; 1998 Mar; 155(2):182-5. PubMed ID: 9562264
[TBL] [Abstract][Full Text] [Related]
24. Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation.
El-Hattab AW; Hsu JW; Emrick LT; Wong LJ; Craigen WJ; Jahoor F; Scaglia F
Mol Genet Metab; 2012 Apr; 105(4):607-14. PubMed ID: 22325939
[TBL] [Abstract][Full Text] [Related]
25. MELAS and L-arginine therapy: pathophysiology of stroke-like episodes.
Koga Y; Povalko N; Nishioka J; Katayama K; Kakimoto N; Matsuishi T
Ann N Y Acad Sci; 2010 Jul; 1201():104-10. PubMed ID: 20649546
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic regimen of L-arginine for MELAS: 9-year, prospective, multicenter, clinical research.
Koga Y; Povalko N; Inoue E; Nakamura H; Ishii A; Suzuki Y; Yoneda M; Kanda F; Kubota M; Okada H; Fujii K
J Neurol; 2018 Dec; 265(12):2861-2874. PubMed ID: 30269300
[TBL] [Abstract][Full Text] [Related]
27. L-arginine is effective in stroke-like episodes of MELAS associated with the G13513A mutation.
Shigemi R; Fukuda M; Suzuki Y; Morimoto T; Ishii E
Brain Dev; 2011 Jun; 33(6):518-20. PubMed ID: 20832210
[TBL] [Abstract][Full Text] [Related]
28. Brain MRS correlates with mitochondrial dysfunction biomarkers in MELAS-associated mtDNA mutations.
Gramegna LL; Evangelisti S; Di Vito L; La Morgia C; Maresca A; Caporali L; Amore G; Talozzi L; Bianchini C; Testa C; Manners DN; Cortesi I; Valentino ML; Liguori R; Carelli V; Tonon C; Lodi R
Ann Clin Transl Neurol; 2021 Jun; 8(6):1200-1211. PubMed ID: 33951347
[TBL] [Abstract][Full Text] [Related]
29. Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial.
Ohsawa Y; Hagiwara H; Nishimatsu SI; Hirakawa A; Kamimura N; Ohtsubo H; Fukai Y; Murakami T; Koga Y; Goto YI; Ohta S; Sunada Y;
J Neurol Neurosurg Psychiatry; 2019 May; 90(5):529-536. PubMed ID: 29666206
[TBL] [Abstract][Full Text] [Related]
30. Effects of exercise-induced intracellular acidosis on the phosphocreatine recovery kinetics: a 31P MRS study in three muscle groups in humans.
Layec G; Malucelli E; Le Fur Y; Manners D; Yashiro K; Testa C; Cozzone PJ; Iotti S; Bendahan D
NMR Biomed; 2013 Nov; 26(11):1403-11. PubMed ID: 23703831
[TBL] [Abstract][Full Text] [Related]
31. The Usefulness of Muscle Biopsy in Initial Diagnostic Evaluation of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes.
Baek MS; Kim SH; Lee YM
Yonsei Med J; 2019 Jan; 60(1):98-105. PubMed ID: 30554496
[TBL] [Abstract][Full Text] [Related]
32. Altered spontaneous brain activity at attack and remission stages in patients with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS): Beyond stroke-like lesions.
Wang R; Li Y; Lin J; Sun C; Chen N; Xu W; Hu B; Liu X; Geng D; Yang L
Mitochondrion; 2020 Sep; 54():49-56. PubMed ID: 32679169
[TBL] [Abstract][Full Text] [Related]
33. Assessment of Nitric Oxide Production in Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Syndrome with the Use of a Stable Isotope Tracer Infusion Technique.
El-Hattab AW; Jahoor F
J Nutr; 2017 Jul; 147(7):1251-1257. PubMed ID: 28515163
[TBL] [Abstract][Full Text] [Related]
34. Carbon 13-labeled magnetic resonance spectroscopy observation of cerebral glucose metabolism: metabolism in MELAS: case report.
Otsuki T; Kanamatsu T; Tsukada Y; Goto Y; Okamoto K; Watanabe H
Arch Neurol; 2005 Mar; 62(3):485-7. PubMed ID: 15767517
[TBL] [Abstract][Full Text] [Related]
35. The influence of maximal aerobic power on recovery of skeletal muscle following anaerobic exercise.
Cooke SR; Petersen SR; Quinney HA
Eur J Appl Physiol Occup Physiol; 1997; 75(6):512-9. PubMed ID: 9202947
[TBL] [Abstract][Full Text] [Related]
36. Effect of long-term oral treatment with L-arginine and idebenone on the prevention of stroke-like episodes in an adult MELAS patient.
Lekoubou A; Kouamé-Assouan AE; Cho TH; Luauté J; Nighoghossian N; Derex L
Rev Neurol (Paris); 2011 Nov; 167(11):852-5. PubMed ID: 21514942
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial DNA and RNA processing in MELAS.
Kaufmann P; Koga Y; Shanske S; Hirano M; DiMauro S; King MP; Schon EA
Ann Neurol; 1996 Aug; 40(2):172-80. PubMed ID: 8773598
[TBL] [Abstract][Full Text] [Related]
38. Epilepsy Characteristics and Clinical Outcome in Patients With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS).
Lee HN; Eom S; Kim SH; Kang HC; Lee JS; Kim HD; Lee YM
Pediatr Neurol; 2016 Nov; 64():59-65. PubMed ID: 27671241
[TBL] [Abstract][Full Text] [Related]
39. Survival analysis of a cohort of Chinese patients with mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) based on clinical features.
Zhang Z; Zhao D; Zhang X; Xiong H; Bao X; Yuan Y; Wang Z
J Neurol Sci; 2018 Feb; 385():151-155. PubMed ID: 29406897
[TBL] [Abstract][Full Text] [Related]
40. Application of NMR spectroscopy to monitoring MELAS treatment: a case report.
Möller HE; Wiedermann D; Kurlemann G; Hilbich T; Schuierer G
Muscle Nerve; 2002 Apr; 25(4):593-600. PubMed ID: 11932978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
